BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29606325)

  • 21. SYNTAX Score-II Predicts Long-Term Mortality in Patients Who Underwent Left Main Percutaneous Coronary Intervention Treated With Second-Generation Drug-Eluting Stents.
    He J; Zhao H; Yu X; Li Q; Lv S; Chen F; Jiang T
    Int Heart J; 2017 May; 58(3):344-350. PubMed ID: 28539567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
    Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Capuano M; Viscusi MM; Di Sciascio G
    J Cardiovasc Transl Res; 2018 Dec; 11(6):517-523. PubMed ID: 30276618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet to Lymphocyte Ratio on Admission and Prognosis in Patients with Acute Cardiogenic Pulmonary Edema.
    Demir M; Duyuler PT; Guray U; Celik MC
    J Emerg Med; 2018 Oct; 55(4):465-471. PubMed ID: 30115388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction.
    Azab B; Shah N; Akerman M; McGinn JT
    J Thromb Thrombolysis; 2012 Oct; 34(3):326-34. PubMed ID: 22466812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Thurner EM; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Br J Cancer; 2014 May; 110(10):2524-30. PubMed ID: 24675383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction.
    Ozcan Cetin EH; Cetin MS; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
    Angiology; 2016 Apr; 67(4):336-45. PubMed ID: 26101368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverse Association between Platelet-Lymphocyte Ratio and Prognosis in Terminally Ill Cancer Patients: A Preliminary Study.
    Lee Y; Kim YW; Park DK; Hwang IC
    J Palliat Med; 2017 May; 20(5):533-537. PubMed ID: 27858496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet to Lymphocyte Ratio Can be a Predictor of Infarct-Related Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction.
    Yayla Ç; Akboğa MK; Canpolat U; Akyel A; Yayla KG; Doğan M; Yeter E; Aydoğdu S
    Angiology; 2015 Oct; 66(9):831-6. PubMed ID: 25712290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental prognostic value of cardiac computed tomography in coronary artery disease using CONFIRM: COroNary computed tomography angiography evaluation for clinical outcomes: an InteRnational Multicenter registry.
    Chow BJ; Small G; Yam Y; Chen L; Achenbach S; Al-Mallah M; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Cheng V; Chinnaiyan KM; Delago A; Dunning A; Hadamitzky M; Hausleiter J; Kaufmann P; Lin F; Maffei E; Raff GL; Shaw LJ; Villines TC; Min JK;
    Circ Cardiovasc Imaging; 2011 Sep; 4(5):463-72. PubMed ID: 21730027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease.
    Aksakal E; Tanboga IH; Kurt M; Kaygın MA; Kaya A; Isik T; Ekinci M; Sevimli S; Acikel M
    Atherosclerosis; 2012 Apr; 221(2):596-601. PubMed ID: 22369933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
    Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
    Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
    Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
    Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
    Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
    BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: Results from the 5 year follow-up of the CONFIRM International Multicenter Registry.
    Cheruvu C; Precious B; Naoum C; Blanke P; Ahmadi A; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Min JK; Leipsic J
    J Cardiovasc Comput Tomogr; 2016; 10(1):22-7. PubMed ID: 26719237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet to lymphocyte ratio predicts all-cause mortality in patients with carotid arterial disease.
    Tek M; Çetin MS; Diker E; Çelebi S; Amasyali B; Berkalp B
    Rom J Intern Med; 2019 Jun; 57(2):159-165. PubMed ID: 30521474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.